Skip to main content
Livermore
Livermore
ZHEN

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

IONS holding history

Ionis Pharmaceuticals Inc in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IONS overviewAll 13F holders of IONSFull Q2 2026 holdings

Shares (Q2 2026)
26,687
Value
$2.12M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of IONS by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202626,687$2.12M<0.1%+303+1.1%AddedHolders
Q1 202626,384$1.98M<0.1%+3,443+15.0%AddedHolders
Q4 202522,941$1.81M<0.1%+1,491+7.0%AddedHolders
Q3 202521,450$1.40M<0.1%−1,304−5.7%ReducedHolders
Q2 202522,754$899.0K<0.1%+2,435+12.0%AddedHolders
Q1 202520,319$613.0K<0.1%+980+5.1%AddedHolders
Q4 202419,339$676.1K<0.1%+318+1.7%AddedHolders
Q3 202419,021$762.0K<0.1%+906+5.0%AddedHolders
Q2 202418,115$863.4K<0.1%+1,906+11.8%AddedHolders
Q1 202416,209$702.7K<0.1%−484−2.9%ReducedHolders
Q4 202316,693$844.5K<0.1%−1,143−6.4%ReducedHolders
Q3 202317,836$809.0K<0.1%−430−2.4%ReducedHolders
Q2 202318,266$749.5K<0.1%+339+1.9%AddedHolders
Q1 202317,927$640.7K<0.1%+217+1.2%AddedHolders
Q4 202217,710$668.9K<0.1%+2,170+14.0%AddedHolders
Q3 202215,540$687.0K<0.1%+122+0.8%AddedHolders
Q2 202215,418$571.0K<0.1%+520+3.5%AddedHolders
Q1 202214,898$552.0K<0.1%+8+0.1%AddedHolders
Q4 202114,890$453.0K<0.1%+318+2.2%AddedHolders
Q3 202114,572$489.0K<0.1%−654−4.3%ReducedHolders
Q2 202115,226$607.0K<0.1%+8,423+123.8%AddedHolders
Q1 20216,803$306.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.